Bill Search

  • Introduced
    Feb 02, 2021
  • Passed Senate
    Mar 03, 2021
  • Passed House
    Apr 14, 2021
  • Signed into Law
    Apr 23, 2021
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
S 164
United States Senate Bill
Advancing Education on Biosimilars Act of 2021
Last Action
executive • Apr 23, 2021: Became Public Law No: 117-8. (TXT | PDF)
Latest bill text
Do you support this bill?
Yay Nay

Official Summary/Bill Text

Comments on Bill

Tweets

Whip Lists

Sponsors:
Votes
YES: 412

NO: 8

NOT VOTING: 9

Actions
  • Apr 23, 2021 | executive
    • Signed by President.
    • Became Public Law No: 117-8. (TXT | PDF)
  • Apr 20, 2021 | Senate
    • Presented to President.
  • Apr 14, 2021 | House
    • Mr. Pallone moved to suspend the rules and pass the bill.
    • Considered under suspension of the rules. (consideration: CR H1754-1755)
    • DEBATE - The House proceeded with forty minutes of debate on S. 164.
    • At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
    • Considered as unfinished business. (consideration: CR H1783-1784)
    • On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101). (text: CR H1754)
    • Motion to reconsider laid on the table Agreed to without objection.
  • Mar 08, 2021 | House
    • Received in the House.
    • Held at the desk.
  • Mar 08, 2021 | Senate
    • Message on Senate action sent to the House.
  • Mar 03, 2021 | Senate
    • Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S1021)
    • Passed Senate without amendment by Unanimous Consent. (text: CR S1021)
  • Feb 02, 2021 | Senate
    • Read twice and referred to the Committee on Health, Education, Labor, and Pensions.